Jeff guides strategic investments and coordinates operations for OS Fund’s team of researchers and associates. He also supports the Fund’s portfolio companies with strategy, execution, partnership and operational expertise.
In 2014, Bryan invested $100M to start OS Fund, which invests in scientist entrepreneurs predictably engineering atoms, molecules, organisms and complex systems.
Lily is an expert in early-stage life sciences commercialization. She attended both Harvard and MIT and concentrated in Electrical and Biomedical Engineering. Prior to OS Fund she was part of the business development team at the Wyss Institute.
Omar advises in the areas of Biomaterials, Immunotherapy, Materials Science and Drug Delivery. He received his PhD from Harvard University in Engineering and Applied Sciences with a focus in Bioengineering.
Gina manages administrative, PMO, benefits/payroll, social media marketing, and special event functions for OS Fund, as well as provides support to the firm’s co-Founders.
Mark has been a part of the investment team since the founding of OS Fund. In his time at OS Fund he has focused on diligence and sourcing of deals across Genomics, Synthetic Biology, and Advanced Materials.
Dan focuses on the sourcing and diligence of investments across synthetic and computational biology, advanced materials, robotic systems, and nextgen compute, and provides strategic support to portfolio companies.
Tariq advises in the areas of Synthetic Biology and Genome Editing. He received his PhD from University of California, Riverside in Cell and Molecular Biology, after which he served as a Postdoctoral Fellow at Harvard Medical School.
Jonathan joined the firm in 2019 and serves the team in areas of finance, investor relations, operations, compliance, marketing, and strategy.
Jonathan obtained his BBA with a major in accounting from the University of Wisconsin - Madison.